Immune Cell Engineering Market Anticipated to Reach US$ 2.82 Billion by 2023

Immune Cell Engineering Market


Market Overview:

The global Immune Cell Engineering Market is estimated to be valued at US$ 2.82 billion in 2023 and is anticipated to exhibit a CAGR of 22.5% over the forecast period of 2023-2030, according to a new report published by Coherent Market Insights. Immune cell engineering refers to the process of modifying immune cells to enhance their therapeutic potential in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. The growing prevalence of these conditions, coupled with the increasing demand for personalized medicine, has led to the rising popularity of immune cell engineering products. These products offer several advantages, including targeted therapy, reduced side effects, and improved patient outcomes. As a result, there is a growing need for immune cell engineering products in the healthcare industry.

Market Key Trends:
One key trend in the Immune Cell Engineering Market is the growing adoption of chimeric antigen receptor (CAR) T-cell therapy. CAR T-cell therapy involves modifying a patient's T-cells to express a CAR, which enables them to recognize and target specific cancer cells. This therapy has shown promising results in the treatment of hematological malignancies, such as leukemia and lymphoma, and has gained approval from regulatory authorities. The market is witnessing an increasing number of collaborations and partnerships, aimed at advancing CAR T-cell therapy development and commercialization. Moreover, ongoing research and development activities are focused on improving the safety and efficacy of CAR T-cell therapy, expanding its application to solid tumors, and reducing manufacturing costs. The growing adoption of CAR T-cell therapy is expected to drive the growth of the Immune Cell Engineering Market over the forecast period.

Segment Analysis

In the Immune Cell Engineering market, the segment of CAR-T Cell Therapy is expected to dominate over the forecast period. CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary treatment approach that harnesses the power of a patient's own immune cells to fight cancer. It involves engineering T-cells to express a specific receptor that recognizes and attacks cancer cells.

The dominating sub-segment within CAR-T Cell Therapy is the CD19-targeted therapy. CD19 is a protein that is commonly found on the surface of cancer cells in certain types of leukemia and lymphoma. This makes it a suitable target for CAR-T cell therapy, as the engineered cells can specifically recognize and eliminate CD19-positive cancer cells.

The CD19-targeted CAR-T therapy has shown remarkable efficacy in clinical trials, leading to its approval for the treatment of certain types of leukemia and lymphoma. It has demonstrated high response rates and durable remissions in patients who have failed standard treatments. As a result, it is expected to dominate the Immune Cell Engineering market over the forecast period.

Key Takeaways

The Global Immune Cell Engineering Market Size is expected to witness high growth, exhibiting a CAGR of 22.5% over the forecast period. This growth can be attributed to the increasing prevalence of cancer and the growing demand for personalized medicine. The advent of CAR-T cell therapy and other immune cell engineering technologies has revolutionized the treatment landscape, offering new hope for patients who have exhausted conventional therapies.

From a regional analysis perspective, North America is expected to be the fastest-growing and dominating region in the Immune Cell Engineering market. This can be attributed to the presence of key players, such as Thermo Fisher Scientific, Merck KGaA, and Danaher Corporation, who are actively engaged in research and development activities in this field. Additionally, the favorable regulatory environment and strong healthcare infrastructure in North America contribute to its dominance in the market.

Key players operating in the Immune Cell Engineering market include Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Miltenyi Biotec, Takara Bio Group, CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Bio-Techne Corporation, Bio-Rad Laboratories, BD, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Corporation, AGC Biologics, Catalent, WuXi AppTec, and ReachBio LLC. These key players are actively involved in developing innovative immune cell engineering technologies and are focused on expanding their market presence through strategic partnerships and acquisitions.


Comments

Post a Comment

Popular posts from this blog

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi
Read more

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man
Read more